ObGyn News and Research

RSS

High antioxidant diet linked to lower risk of cervical cancer in women

In research published in the International Journal of Gynecology & Obstetrics, a diet high in antioxidants was linked with a lower risk of cervical cancer in women.

19 Aug 2026

Prenatal strength training may help reduce the risk of gestational diabetes

Various forms of physical exercise may help prevent diabetes during pregnancy (or gestational diabetes), but data are limited. In a randomized clinical trial published in Acta Obstetricia et Gynecologica Scandinavica including 209 pregnant women, participants who followed a strength training program from gestational weeks 12–14 until week 36 or delivery had lower rates of gestational diabetes.

19 Aug 2026

Neighborhood conditions help explain racial disparities in ovarian cancer survival

A new study led by researchers at the University of Pittsburgh found that women living in socially vulnerable communities face a 20% higher risk of death after an ovarian cancer diagnosis compared with women living in less vulnerable communities.

10 Aug 2026

Review highlights pregnancy and miscarriage rates among transmasculine people

A recent review of published research provides some evidence that a small but noteworthy minority of transmasculine people (trans, nonbinary, and other gender expansive people who were assigned female at birth) have pregnancies (6%–9%) and children (4%–9%), including after transition.

8 Jul 2026

MSU researchers develop tool to observe complex molecular choreography in real time

A lot of things need to go right on a molecular level for immune cells to launch an adaptive response to an infection.

23 Jun 2026

Mycoplasma genitalium unlikely to drive recurrent preterm deliveries

A new study from UTHealth Houston found that the common sexually transmitted infection, Mycoplasma genitalium, also known as MGen, does not appear to increase the risk of recurrent preterm birth.

9 Jun 2026

Yōni.Fit expands use for menstrual discharge management

Watkins-Conti Products, Inc. ("Watkins-Conti"), a company that develops innovative solutions for women's pelvic health, today announced the Company has added a second indication for its flagship product, the Yōni.Fit Bladder Support ("Yōni.Fit").

24 Apr 2026

Immune switch plays a critical role in successful pregnancies

Early pregnancy depends on a remarkable act of coordination. Before the placenta can nourish a growing fetus, the embryo must securely "land" and connect with the mother's blood supply - a process guided by a specialized group of immune cells called uterine natural killer cells, or uNK cells.

12 Mar 2026

New strategy boosts immunotherapy against aggressive ovarian cancer

Cells in our immune system are best known for providing security against external invaders such as bacteria and viruses. These immune cells also guard against internal threats, including cancerous tumors.

5 Mar 2026

FDA clears cloud-based AI system to forecast predicted delivery date

Ultrasound AI, a pioneer in artificial intelligence applications for medical imaging, today announced it has received FDA De Novo clearance for its flagship Delivery Date AI technology, a cloud-based SaMD that determines a Predicted Delivery Date (PDD) solely from standard ultrasound images and seamless integration into current OB/MFM prenatal visit workflows; PDD is provided in real-time for actionable decision-making by the clinical team.

2 Mar 2026

Gaps persist in evidence-based care for preterm infants

Prenatal magnesium sulfate and steroids can reduce the risks of cerebral palsy and respiratory complications in preterm infants.

25 Feb 2026

ARPA-H-funded PROSPR program focuses on the biological hallmarks of aging

Columbia University Mailman School of Public Health has received an award as part of the PROactive Solutions for Prolonging Resilience (PROSPR) program within the Advanced Research Projects Agency for Health (ARPA-H) to accelerate research on the biological hallmarks of aging.

24 Feb 2026

Standard doses of antidepressants during pregnancy appear to be safe, study suggests

Using a standard dose of antidepressants during pregnancy appears to be safe for the baby, suggests new research from the University of Oslo and Akershus University Hospital.

24 Feb 2026

Study examines the effectiveness of urine testing as a screening tool for alcohol use in pregnancy

Previous reports have indicated that between 20 and 60 per cent of pregnant women in Ireland consume alcohol during pregnancy.

18 Feb 2026

Prior abortion or miscarriage not linked to increased risk of pre- or postmenopausal breast cancer

A prior abortion or miscarriage was not linked with an increased risk of developing pre- or postmenopausal breast cancer in a study published in Acta Obstetricia et Gynecologica Scandinavica.

11 Feb 2026

Insulin anxiety and workplace barriers complicate gestational diabetes care

Insulin use in gestational diabetes presents challenges; education and support are key to overcoming fears and ensuring effective self-management for mothers.

20 Jan 2026

Inside the battle for the future of addiction medicine

Elyse Stevens had a reputation for taking on complex medical cases. People who'd been battling addiction for decades. Chronic-pain patients on high doses of opioids. Sex workers and people living on the street.

7 Jan 2026

Irregular collagen in uterine scars linked to placenta accreta development

Placenta accreta spectrum (PAS) used to be a rare pregnancy condition, but it now affects roughly 14,000 pregnancies annually, posing a major cause of maternal death.

2 Jan 2026

AI scribe survey reveals patient preferences for medical note-taking

Electronic medical records (EMRs) have been a tremendous benefit in exam rooms across the country, creating secure patient history databases that clinicians can easily access and update. Yet, they can also detract from the doctor-patient experience, as physicians must type notes into the system rather than devote their complete attention to patients.

17 Dec 2025

UTHealth Houston researchers receive NIH grant for fetoscopic spina bifida repair study

A five-year, $2.8 million grant was awarded to researchers at UTHealth Houston by the National Institutes of Health to evaluate the long-term effects on patients enrolled in the "Cryopreserved Human Umbilical Cord as a Meningeal Patch in Fetoscopic Spina Bifida Repair" trial.

1 Dec 2025